Cargando…
A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
AIMS: A prospective meta‐analysis of phase 3 trials showed lower rates of nocturnal hypoglycaemia with insulin degludec vs. insulin glargine. We investigated the consistency of the results across different definitions of hypoglycaemia. METHODS: This post‐hoc, patient‐level meta‐analysis included six...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064738/ https://www.ncbi.nlm.nih.gov/pubmed/26484727 http://dx.doi.org/10.1111/dme.13002 |
_version_ | 1782460219635269632 |
---|---|
author | Heller, S. Mathieu, C. Kapur, R. Wolden, M. L. Zinman, B. |
author_facet | Heller, S. Mathieu, C. Kapur, R. Wolden, M. L. Zinman, B. |
author_sort | Heller, S. |
collection | PubMed |
description | AIMS: A prospective meta‐analysis of phase 3 trials showed lower rates of nocturnal hypoglycaemia with insulin degludec vs. insulin glargine. We investigated the consistency of the results across different definitions of hypoglycaemia. METHODS: This post‐hoc, patient‐level meta‐analysis included six randomized, controlled, 26‐ or 52‐week phase 3a trials in insulin‐naïve participants with Type 2 diabetes mellitus (Type 2 diabetes(insulin naïve)), participants with Type 2 diabetes mellitus using basal−bolus therapy (Type 2 diabetes(BB)) and those with Type 1 diabetes mellitus. We used three definitions of hypoglycaemia and different timescales for the nocturnal period. Rates were analysed for the entire core trial period, the ‘maintenance period’ only, and the extension trial set population. Analyses utilized a negative binomial regression model. RESULTS: In Type 2 diabetes(insulin naïve) participants, risk of nocturnal hypoglycaemia was significantly lower with insulin degludec vs. insulin glargine for all hypoglycaemia definitions and trial periods. Risk was also lower for the timescale 21.59–05.59, but not 00.01–07.59. For Type 2 diabetes(BB), nocturnal hypoglycaemia rates were lower with insulin degludec vs. insulin glargine across all definitions, timescales and trial periods, with one exception. For individuals with Type 1 diabetes mellitus, nocturnal hypoglycaemia risk was significantly lower with insulin degludec during the maintenance period for the original definition (plasma glucose < 3.1 mmol/l, timescale 00.01–05.59) and in the extension trial set population for all hypoglycaemia definitions except for the nocturnal timescale 00.01–07.59. CONCLUSIONS: Compared with insulin glargine, insulin degludec is associated with lower rates of nocturnal hypoglycaemia in people with Type 2 diabetes mellitus, and similar or lower rates in Type 1 diabetes mellitus, across different definitions. |
format | Online Article Text |
id | pubmed-5064738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50647382016-10-19 A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia Heller, S. Mathieu, C. Kapur, R. Wolden, M. L. Zinman, B. Diabet Med Research Articles AIMS: A prospective meta‐analysis of phase 3 trials showed lower rates of nocturnal hypoglycaemia with insulin degludec vs. insulin glargine. We investigated the consistency of the results across different definitions of hypoglycaemia. METHODS: This post‐hoc, patient‐level meta‐analysis included six randomized, controlled, 26‐ or 52‐week phase 3a trials in insulin‐naïve participants with Type 2 diabetes mellitus (Type 2 diabetes(insulin naïve)), participants with Type 2 diabetes mellitus using basal−bolus therapy (Type 2 diabetes(BB)) and those with Type 1 diabetes mellitus. We used three definitions of hypoglycaemia and different timescales for the nocturnal period. Rates were analysed for the entire core trial period, the ‘maintenance period’ only, and the extension trial set population. Analyses utilized a negative binomial regression model. RESULTS: In Type 2 diabetes(insulin naïve) participants, risk of nocturnal hypoglycaemia was significantly lower with insulin degludec vs. insulin glargine for all hypoglycaemia definitions and trial periods. Risk was also lower for the timescale 21.59–05.59, but not 00.01–07.59. For Type 2 diabetes(BB), nocturnal hypoglycaemia rates were lower with insulin degludec vs. insulin glargine across all definitions, timescales and trial periods, with one exception. For individuals with Type 1 diabetes mellitus, nocturnal hypoglycaemia risk was significantly lower with insulin degludec during the maintenance period for the original definition (plasma glucose < 3.1 mmol/l, timescale 00.01–05.59) and in the extension trial set population for all hypoglycaemia definitions except for the nocturnal timescale 00.01–07.59. CONCLUSIONS: Compared with insulin glargine, insulin degludec is associated with lower rates of nocturnal hypoglycaemia in people with Type 2 diabetes mellitus, and similar or lower rates in Type 1 diabetes mellitus, across different definitions. John Wiley and Sons Inc. 2015-12-13 2016-04 /pmc/articles/PMC5064738/ /pubmed/26484727 http://dx.doi.org/10.1111/dme.13002 Text en © 2015 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Heller, S. Mathieu, C. Kapur, R. Wolden, M. L. Zinman, B. A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia |
title | A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia |
title_full | A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia |
title_fullStr | A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia |
title_full_unstemmed | A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia |
title_short | A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia |
title_sort | meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064738/ https://www.ncbi.nlm.nih.gov/pubmed/26484727 http://dx.doi.org/10.1111/dme.13002 |
work_keys_str_mv | AT hellers ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia AT mathieuc ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia AT kapurr ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia AT woldenml ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia AT zinmanb ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia AT hellers metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia AT mathieuc metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia AT kapurr metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia AT woldenml metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia AT zinmanb metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia |